LTS – your B2B partner to the pharmaceutical industry
Competent, trustful and individually tailored to the needs of our partners: This is how we create the best conditions for the greatest possible success of a new drug.
What LTS contributes
LTS leads the way in transdermal therapy systems (LTS TTS) and oral thin films (LTS OTF). As a B2B partner to the pharmaceutical industry, we offer solutions at all stages of drug development: from feasibility assessments, research and development of new formulations to clinical trials (up to phase II), production and packaging.
Patches – an attractive niche in the pharmaceuticals market
With sales of around €4.9 billion, the transdermal therapeutic system (TTS) market makes up a very small part of this. Nevertheless TTS are an attractive niche in the global pharmaceuticals market.
Good reasons for choosing LTS
The path from the developed substance to the successful transdermal therapeutic system (TTS) or oral thin film (OTF) is a long and labour-intensive one. As such, you need a strong, experienced and commited partner at your side. LTS as the market leader fulfils all these requirements.
LTS as a partner for healthcare innovations
LTS covers in a single source all the relevant technical steps in drug development – from feasibility studies for your drug up to the market launch and subsequent large scale manufacturing. LTS manufactures for the global markets of your choice – make use of our expertise as an innovative market leader.